Accès ouvert
2026
article
OpenAlex
Elias David Lundereng, Alen Brkic, Kate L. Absolom, Elisabeth Andvik et autres
PURPOSE: Patient-centered care (PCC) improves quality of life, symptom management and healthcare outcomes in oncology. However, integration into routine cancer care remains limited. Digital solutions using patient-reported outcome measures (PROMs) offer a potential mechanism to operationalize PCC. This study explored healthcare professionals' …
no, gb, be, es, dk, ro, nl, de, it, ch
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Jo‐Åsmund Lund, Birutė Strukčinskienė, Thaynná Stephane Campos Alves, Christos D Lionis et autres
Abstract Background and Objectives Injuries and violence remain leading causes of avoidable death and disability across Europe, yet their burden is often underestimated in public health agendas. The Injury Prevention and Safety Promotion Section of the European Public Health Association (EUPHA INJ) …
no, lt, pt, gr, dk, me
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Terese Solvoll Skåre, Tonje Lundeby, Jo‐Åsmund Lund, Elias David Lundereng et autres
Background: Systematic symptom management is a crucial component in patient-centered cancer care. Despite the development of numerous electronic patient-reported outcome measure (ePROM) tools, integrating these tools into clinical practice remains challenging. Engaging key stakeholders, including patients, in the development of ePROM tools …
no, be
(code pays fourni par la source)
2025
preprint
OpenAlex
Terese Solvoll Skåre, Tonje Lundeby, Jo‐Åsmund Lund, Elias David Lundereng et autres
BACKGROUND Systematic symptom management is a crucial component in patient-centred cancer care. Despite advancements in symptom management and the development of numerous electronic patient-reported outcome tools (ePROMs), integrating these tools into clinical practice remains challenging. As part of an innovation and implementation …
Accès ouvert
2024
article
OpenAlex
Olav Erich Yri, Guro Lindviksmoen Astrup, Astrid Telhaug Karlsson, René van Helvoirt et autres
Background: A major concern in anticancer treatment (ACT) of brain metastases (BM) is exposing patients with short expected survival to treatments that negatively impact on quality of life (QoL). Such futile ACT at the end of life is time-consuming and burdensome for …
no
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Jo‐Åsmund Lund
Abstract Introduction We have little information about long term effects of injuries resulting in disability. In addition to human suffering and reduced quality of life, these consequences of injuries inflict a heavy burden on the national economy. All persons in Norway aged …
no
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Katarina Puco, Gro Live Fagereng, Sigmund Brabrand, Pitt Niehusmann et autres
BACKGROUND AND PURPOSE: In Norway, comprehensive molecular tumour profiling is implemented as part of the public healthcare system. A substantial number of tumours harbour potentially targetable molecular alterations. Therapy outcomes may improve if targeted treatments are matched with actionable genomic alterations. In …
no
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Anne‐Tove Brenne, Erik Torbjørn Løhre, Anne Kari Knudsen, Jo‐Åsmund Lund et autres
Patients with cancer often want to spend their final days at home. In Norway, most patients with cancer die in institutions. We hypothesized that full integration of oncology and palliative care services would result in more time spent at home during end-of-life. …
no, it
(code pays fourni par la source)
2024
article
OpenAlex
Jo‐Åsmund Lund, Stian Lydersen, Bjørg Y. Aksnessæther, Arne Solberg et autres
no
(code pays fourni par la source)
Accès ouvert
2022
article
OpenAlex
Siri Tessem Mørkeset, Christoffer Lervåg, Jo‐Åsmund Lund
This clinical study aimed to evaluate lung cancer patients' ability to perform deep inspiration breath-hold (DIBH) during CT simulation and throughout the treatment course of stereotactic body radiation therapy (SBRT). In addition, target sizes, organ at risk (OAR) sizes, and doses to …
no
(code pays fourni par la source)
Accès ouvert
2022
erratum
OpenAlex
Åslaug Helland, Hege Giercksky Russnes, Gro Live Fagereng, Khalid I. Al-Shibli et autres
no
(code pays fourni par la source)
Accès ouvert
2022
article
OpenAlex
Åslaug Helland, Hege Giercksky Russnes, Gro Live Fagereng, Khalid I. Al-Shibli et autres
BACKGROUND: Matching treatment based on tumour molecular characteristics has revolutionized the treatment of some cancers and has given hope to many patients. Although personalized cancer care is an old concept, renewed attention has arisen due to recent advancements in cancer diagnostics including …
no
(code pays fourni par la source)